|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes, net | |||||
| Premium and discount amortization on available-for-sale securities and bank loans and net unrealized gains/losses on other investments | |||||
| Provisions for credit losses and legal and regulatory matters | |||||
| Share-based compensation expense | |||||
| Unrealized gains on corporate-owned life insurance policies, net of expenses | |||||
| Losses on extinguishment of debt | |||||
| Other | |||||
| Net change in: | |||||
| Assets segregated for regulatory purposes excluding cash and cash equivalents | |||||
| Collateralized agreements, net of collateralized financings | |||||
| Loans (provided to) financial advisors, net of repayments | |||||
| Brokerage client receivables and other receivables, net | |||||
| Trading instruments, net | |||||
| Derivative instruments, net | |||||
| Other assets | |||||
| Brokerage client payables and other payables | |||||
| Accrued compensation, commissions and benefits | |||||
| Purchases and originations of loans held for sale, net of proceeds from sales of securitizations and loans held for sale | |||||
| Net cash provided by/(used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Increase in bank loans, net | |||||
| Proceeds from sales of loans held for investment | |||||
| Purchases of available-for-sale securities | |||||
| Available-for-sale securities maturations, repayments and redemptions | |||||
| Proceeds from sales of available-for-sale securities | |||||
| Cash and cash equivalents acquired in business acquisitions, including those segregated for regulatory purposes, net of cash paid for acquisitions | |||||
| Additions to property and equipment | |||||
| Purchase of Federal Reserve Bank stock | |||||
| Purchases of Federal Home Loan Bank stock, net | |||||
| Sales/(purchases) of Federal Reserve Bank (“FRB”) and Federal Home Loan Bank (“FHLB”) stock, net | |||||
| Investment in note receivable | |||||
| Renewable energy tax credit equity investments | |||||
| Sales/(purchases) of other investments, net | |||||
| Other investing activities, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from senior notes issuances, net of debt issuance costs paid | |||||
| Extinguishment of senior notes payable | |||||
| Increase in bank deposits | |||||
| Repurchases of common stock and share-based awards withheld for payment of withholding tax requirements | |||||
| Dividends on common and preferred stock | |||||
| Exercise of stock options and employee stock purchases | |||||
| Redemption of preferred stock | |||||
| Proceeds from senior notes issuance, net of debt issuance costs paid | |||||
| Redemption of subordinated notes | |||||
| Proceeds from FHLB advances | |||||
| Repayments of FHLB advances | |||||
| Other financing, net | |||||
| Net cash provided by financing activities | |||||
| Currency adjustment: | |||||
| Effect of exchange rate changes on cash and cash equivalents, including those segregated for regulatory purposes | |||||
| Net increase/(decrease) in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash | |||||
| Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at beginning of year | |||||
| Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net | |||||
| Cash outflows for lease liabilities | |||||
| Non-cash right-of-use (“ROU”) lease assets recorded for new and modified leases | |||||
| Stock issued as consideration for TriState Capital acquisition | |||||
| Common stock, par value $.01 per share | |||||
| Preferred stock | |||||
| Restricted stock awards issued as consideration for TriState Capital acquisition | |||||
| Effective settlement of note receivable for TriState Capital acquisition | |||||
| Cash and cash equivalents, including those segregated for regulatory purposes and restricted cash | |||||
| Cash and cash equivalents | |||||
| Cash and cash equivalents segregated for regulatory purposes and restricted cash | |||||
Loading...